These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22459898)

  • 1. p53 in pure epithelioid PEComa: an immunohistochemistry study and gene mutation analysis.
    Bing Z; Yao Y; Pasha T; Tomaszewski JE; Zhang PJ
    Int J Surg Pathol; 2012 Apr; 20(2):115-22. PubMed ID: 22459898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
    Pan CC; Chung MY; Ng KF; Liu CY; Wang JS; Chai CY; Huang SH; Chen PC; Ho DM
    J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis.
    Sato K; Ueda Y; Tachibana H; Miyazawa K; Chikazawa I; Kaji S; Nojima T; Katsuda S
    Pathol Res Pract; 2008; 204(10):771-7. PubMed ID: 18547741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in renal epithelioid angiomyolipoma.
    Li W; Guo L; Bi X; Ma J; Zheng S
    Int J Clin Exp Pathol; 2015; 8(8):9446-51. PubMed ID: 26464702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
    Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
    Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features of uterine neoplasms with perivascular epithelioid cell differentiation].
    Lu HZ; Zhang HT; Liu XY; Xue XH; Xie YQ; Liu SM; Su Q
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):213-6. PubMed ID: 19615263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal imbalances detected by comparative genomic hybridization provide evidence that HMB-45-negative uterine angiomyolipomas belong to the PEComa family.
    Kawauchi S; Nawata H; Yamagata Y; Yaegashi H; Fukunaga M; Moriya T; Furuya T; Sugino N; Sasaki K
    Histopathology; 2010 Jun; 56(7):974-7. PubMed ID: 20636800
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis.
    Deng YF; Lin Q; Zhang SH; Ling YM; He JK; Chen XF
    Pathol Res Pract; 2008; 204(12):911-8. PubMed ID: 18723294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
    Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
    Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
    CaliĆ² A; Brunelli M; Gobbo S; Pedron S; Segala D; Argani P; Martignoni G
    Pathology; 2021 Aug; 53(5):579-585. PubMed ID: 33461798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
    Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
    Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concept of perivascular epithelioid cells and neoplasms with perivascular epithelioid cell differentiation].
    Cai JN; Shi M; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):59-64. PubMed ID: 21429366
    [No Abstract]   [Full Text] [Related]  

  • 18. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
    CaliĆ² A; Ammendola S; Brunelli M; Pedron S; Gobbo S; Martignoni G
    Virchows Arch; 2021 Apr; 478(4):785-791. PubMed ID: 32524185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.